

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
According to the latest report by IMARC Group, titled “ External Defibrillators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
” the global external defibrillators market reached a strong growth in 2021.
External defibrillators are compact devices designed to treat individuals experiencing sudden cardiac arrests (SCA). They examine the heart rhythm and deliver an electric shock to reinstate normal heart rhythm. They consist of a battery and pad electrodes vital for the external defibrillators to detect and interpret an electrocardiogram. They are even used by non-medical individuals, including police officers, flight attendants, teachers, lifeguards, bystanders, and family members of high-risk persons.
One of the primary factors driving the market is the extensive prevalence of out-of-hospital cardiac arrest (OHCA), determined by the absence of systemic circulation and the loss of mechanical cardiac functions. Additionally, the rising instances of people suffering from diabetes, hypertension, and obesity due to physical inactivity, rising consumption of alcohol and tobacco, and unhealthy diet is propelling the market growth.
Besides this, external defibrillators are widely being installed in public areas, including shopping malls, businesses, hotels, sports venues, offices, convention centers, aircraft, and schools. Furthermore, some external defibrillators are equipped with a pediatric attenuator system to minimize the delivered energy to a dose suitable for children, thus catalyzing the market growth. Along with this, advanced external defibrillators are easy to operate, economical, and safe for users, which is expected to create a positive market outlook in the near future.
Looking forward, the market value is projected to reach a strong growth during the forecast period (2022-2027).
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.